Latest News about AZN
Recent news which mentions AZN
Could This New Drug Launch Be a Hit for Viatris?
January 12, 2023
From Motley Fool
From Benzinga
Why Is CinCor (CINC) Stock Up 138% Today?
January 09, 2023
From InvestorPlace
From Benzinga
From Benzinga
From InvestorPlace
From MarketWatch
Powell won’t stop rate hikes until he ‘terrifies’ the wealthiest of investors, says this CIO
January 09, 2023
From MarketWatch
AstraZeneca will buy U.S.-based CinCor for cardiorenal asset
January 09, 2023
From MarketWatch
1 Stock Defying the Downturn to Buy, and 1 to Avoid
January 06, 2023
From Motley Fool
AstraZeneca's Current Valuation Not Reflective Of Its Strong Fundamentals, Analyst Says
January 05, 2023
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
January 05, 2023
From Benzinga
3 Top Healthcare Stocks Defying the Bear Market
January 03, 2023
From Motley Fool
Valneva Touts Additional Positive Heterologous Booster Data From COVID-19 Vaccine Study
January 03, 2023
From Benzinga
Why Shares of Compugen Rose on Thursday
December 29, 2022
From Motley Fool
Got $1,000? 5 Sensational Stocks to Buy to Start 2023 With a Bang
December 26, 2022
From Motley Fool
2 Market-Beating Stocks to Buy in 2023 and Hold Forever
December 24, 2022
From Motley Fool
The Top Healthcare Stocks to Buy With $100
December 22, 2022
From Motley Fool
Europe Approves AstraZeneca's Two Combo Therapies For Prostate, Bile Duct Cancer Settings
December 21, 2022
From Benzinga
Top M&A Target: Madrigal Pharmaceuticals Could Be Next After Successful NASH Data, Analyst Says
December 20, 2022
From Benzinga
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
December 20, 2022
From Motley Fool
AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs
December 19, 2022
From Benzinga
From Benzinga
AstraZeneca’s Forxiga gets EU approval recommendation for symptomatic chronic heart failure
December 19, 2022
Tickers
AZN
From MarketWatch
AstraZeneca’s Imfinzi plus Imjudo recommended for approval in the EU
December 19, 2022
Tickers
AZN
From MarketWatch
Guardant Health (GH) Stock Sinks on Disappointing Blood Test Results
December 16, 2022
From InvestorPlace
2 Best Biotech Stocks to Buy Right Now
December 16, 2022
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.